Evolutionary Genomics Receives NSF Phase I SBIR Grant

NEW YORK, June 6 - Evolutionary Genomics has received a Phase I Small Business Innovative Research grant from the National Science Foundation, the company said on Wednesday.

The company is planning to use the grant to find genes that protect chimpanzees from developing AIDS when infected with HIV by comparing equivalent genes of humans and chimpanzees.

Evolutionary Genomics, located in FitzsimonsBioscienceParkCenter in Aurora, Colo., has developed a patented method for comparing genes of closely related species and identifying those responsible for adaptations. It applies this method both to human healthcare and agriculture.